AKT2 and T-cell non-Hodgkin lymphoma: MYB, FLT3, and EGR2 have been identified as critical target genes of miR-150 in MLL-rearranged AML, while AKT2 is a direct target of miR-150 in NK/T-cell lymphoma (Fulci et al., 2007; Hussein et al., 2010; Watanabe et al., 2011; Jiang et al., 2012; He Y. et al., 2014).